Cancer Focus Fund

The firm prefers to invest in cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The firm is established in partnership with The University of Texas MD Anderson Cancer Center. Cancer focus fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals. At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials. Our objective is to provide support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of The University of Texas MD Anderson Cancer Center.